Table 2 Changes in clinical serum chemistry and complete blood count variables
From: Efficacy and safety of a popular thermogenic drink after 28 days of ingestion
| Variable | Group | Day 0 | Day 28 | Significance | |
|---|---|---|---|---|---|
|
Triglycerides (mg·dl-1) |
TD PLA |
94 ± 8 94 ± 7 |
105 ± 9 98 ± 7 |
Group: Time: G × T: |
0.77 0.10 0.44 |
|
Total Chol (mg·dl-1) |
TD PLA |
162 ± 5 165 ± 6 |
164 ± 5 168 ± 5 |
Group: Time: G × T: |
0.61 0.32 0.99 |
|
HDL Chol (mg·dl-1) |
TD PLA |
58 ± 3 54 ± 2 |
57 ± 3 54 ± 2 |
Group: Time: G × T: |
0.33 0.92 0.44 |
|
LDL Chol (mg·dl-1) |
TD PLA |
85 ± 4 94 ± 6 |
86 ± 5 94 ± 5 |
Group: Time: G × T: |
0.26 0.73 0.91 |
|
Glucose (mg·dl-1) |
TD PLA |
94 ± 1 91 ± 1 |
96 ± 1 92 ± 1 |
Group: Time: G × T: |
0.07 0.06 0.52 |
|
Sodium (mM)† |
TD PLA |
141 ± 1 141 ± 1 |
142 ± 2 142 ± 2 |
Group: Time: G × T: |
0.93 0.03 0.96 |
|
Potassium (mM) |
TD PLA |
4.4 ± 0.1 4.5 ± 0.1 |
4.5 ± 0.1 4.6 ± 0.1 |
Group: Time: G × T: |
0.20 0.41 0.96 |
|
BUN (mg·dl-1) |
TD PLA |
14 ± 1 14 ± 1 |
14 ± 1 13 ± 1 |
Group: Time: G × T: |
0.63 0.35 0.36 |
|
Creatinine (mg·dl-1)† |
TD PLA |
1.0 ± 0.0 1.0 ± 0.0 |
1.0 ± 0.0 1.0 ± 0.0 |
Group: Time: G × T: |
0.46 0.007 0.42 |
|
ALT (U·L-1) |
TD PLA |
20 ± 2 19 ± 1 |
18 ± 1 18 ± 1 |
Group: Time: G × T: |
0.69 0.12 0.51 |
|
AST (U·L-1) |
TD PLA |
20 ± 1 20 ± 1 |
20 ± 1 21 ± 2 |
Group: Time: G × T: |
0.94 0.53 0.74 |
|
RBC Count (106·μl-1)† |
TD PLA |
5.00 ± 0.12 4.91 ± 0.14 |
4.63 ± 0.08 4.62 ± 0.10 |
Group: Time: G × T: |
0.75 < 0.001 0.68 |
|
Hemoglobin (g·dl-1)† |
TD PLA |
14.5 ± 0.2 14.8 ± 0.3 |
14.2 ± 0.2 14.4 ± 0.3 |
Group: Time: G × T: |
0.42 0.003 0.50 |
|
Hematocrit (%)† |
TD PLA |
43.6 ± 1.6 42.7 ± 0.8 |
40.8 ± 0.7 41.0 ± 0.9 |
Group: Time: G × T: |
0.78 0.02 0.56 |
|
WBC Count (103·μl-1) |
TD PLA |
5.9 ± 0.2 5.9 ± 0.2 |
5.8 ± 0.2 6.1 ± 0.2 |
Group: Time: G × T: |
0.63 0.95 0.36 |
